Jerry McLaughlin is chief executive officer and director for Life Biosciences, a clinical-stage biotechnology company pioneering cellular rejuvenation therapies to reverse and prevent multiple diseases of aging. He has more than 30 years of biopharmaceutical experience, spanning drug discovery, clinical development, and global commercialization. Jerry has contributed to the approval and launch of more than a dozen FDA-approved medicines and has led multiple exits. Most recently, he served as President and CEO of Neos Therapeutics. Previously, he was president and CEO of AgeneBio, a clinical-stage biopharma focused on neurological and psychiatric diseases. He also served in senior management roles at NuPathe, Endo, and Merck & Co. Inc.